DSM: H1 earnings up 14%
(CercleFinance.com) - DSM shares are down 3% in Amsterdam, despite the company reporting a 14% rise in adjusted net profit to 335 million euros for H1 2022, along with adjusted EBITDA that is up 8% at 746 million euros, representing a margin that is down 1.
6 point at 18.1%.
In its continuing health, nutrition and bioscience businesses, group's sales increased 17% to 4.11 billion euros, with organic growth of 10% mainly driven by price and mix effects (+8%) while volumes grew by 2%.
"Whilst acknowledging the challenging global macroeconomic environment, we see continuing good market demand, positive pricing momentum and favorable foreign exchange effects supporting our full year outlook".
Copyright (c) 2022 CercleFinance.com. All rights reserved.